{"symbol": "CBAY", "companyName": "CymaBay Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.cymabay.com", "description": "CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.", "CEO": "Sujal Shah", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}